ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

ACR Convergence

Keynote Speaker Tait Shanafelt, MD

Keynote Speaker Tait Shanafelt, MD

ACR Convergence 2025, the world’s premier rheumatology experience, is underway this week (Oct. 24–29) in Chicago. This in-person event showcased cutting-edge and timely topics in rheumatology, as well as the prevention, diagnosis and treatment of rheumatic diseases and related comorbid conditions. Check out the video highlights here. Below, you’ll find links to our meeting reports, which will be updated frequently. And don’t miss our expert-curated reports on the top research in lupus nephritis and psoriatic arthritis presented at the meeting.

Focused Content

  • Lupus Nephritis FocusRheum

    Renal biopsy showing class III lupus nephritis with rare foci of subendothelial deposits (wire loop lesions).

    In this commentary by lupus expert Graciela S. Alarcón, MD, MPH, MACR, some of the many abstracts on research into lupus nephritis presented at ACR Convergence 2025 are highlighted. The abstracts selected demonstrate the advances made on the early recognition of the condition, as well as offering some hope in terms of achieving better outcomes. And don’t forget to explore our research reviews, case reports and clinical articles.


    VIEW

  • Psoriatic Arthritis FocusRheum

    What new research on psoriatic arthritis has the potential to impact patient care or future research? Expert and founding editor David S. Pisetsky, MD, PhD, a professor of medicine and integrative immunobiology at Duke University School of Medicine, Durham, N.C., and a staff rheumatologist at the Durham VA Medical Center, curated the research presented at ACR Convergence 2025 and answers that question. You’ll find his commentary and much more in this FocusRheum. 


    VIEW

Previous ACR Meetings

Complete Coverage

Lupus Nephritis: A Serious Manifestation of Systemic Lupus Erythematosus

In this review, some of the many abstracts on research into lupus nephritis presented at ACR Convergence 2025 are highlighted. The abstracts selected demonstrate the advances made on the early recognition of the condition, as well as offering some hope in terms of achieving better outcomes.

Lupus Nephritis from Bench to Bedside

Urinary biomarkers may have the potential to detect early treatment responses or failures in patients with lupus nephritis, according to Andrea Fava, MD. He and other experts discussed the latest research into lupus nephritis and how apply the recent ACR guideline to refractory cases.

JIA: The Transition to Adult Care

Experts addressed considerations for how to aid patients with juvenile idiopathic arthritis (JIA) in their transition to adult care, specifically highlighting clinical pearls for those with pediatric uveitis and TMJ arthritis.

The Intersection of Immunology & Rheumatology

The winning case study in this year’s Thieves Market highlight a case study from Malaysia with a patient who initially presented with seronegative inflammatory arthritis but experienced recurrent infections and had a porcelain aorta.

Balancing Optimism & Skepticism in CAR T for SLE

At ACR Convergence 2025, Joan T. Merrill, MD, overviewed the current research landscape of chimeric antigen receptor (CAR) T cell therapies for systemic lupus erythematosus (SLE), raising important scientific questions about these emerging treatments.